KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Cash & Current Investments: 2010-2015

Historic Cash & Current Investments for Biocryst Pharmaceuticals (BCRX) over the last 5 years, with Sep 2015 value amounting to $70.3 million.

  • Biocryst Pharmaceuticals' Cash & Current Investments fell 44.68% to $70.3 million in Q3 2015 from the same period last year, while for Sep 2015 it was $305.0 million, marking a year-over-year decrease of 7.21%. This contributed to the annual value of $72.8 million for FY2014, which is 91.23% up from last year.
  • According to the latest figures from Q3 2015, Biocryst Pharmaceuticals' Cash & Current Investments is $70.3 million, which was down 25.47% from $94.4 million recorded in Q2 2015.
  • Biocryst Pharmaceuticals' 5-year Cash & Current Investments high stood at $132.1 million for Q2 2014, and its period low was $14.8 million during Q1 2013.
  • For the 3-year period, Biocryst Pharmaceuticals' Cash & Current Investments averaged around $64.6 million, with its median value being $67.5 million (2015).
  • Per our database at Business Quant, Biocryst Pharmaceuticals' Cash & Current Investments plummeted by 65.79% in 2013 and then skyrocketed by 568.33% in 2014.
  • Over the past 5 years, Biocryst Pharmaceuticals' Cash & Current Investments (Quarterly) stood at $41.7 million in 2011, then declined by 14.67% to $35.6 million in 2012, then rose by 6.90% to $38.1 million in 2013, then surged by 91.23% to $72.8 million in 2014, then slumped by 44.68% to $70.3 million in 2015.
  • Its Cash & Current Investments was $70.3 million in Q3 2015, compared to $94.4 million in Q2 2015 and $67.5 million in Q1 2015.